Small molecules & peptides

Y-PSMA I&T

reference material for [⁹⁰]Y-PSMA I&T (PSMA: prostate-specific membrane antigen)

natY-(3S,7S,26R,29R,32R)-29-benzyl-32-(4-hydroxy-3-iodobenzyl)-5,13,20,28,31,34-hexaoxo-37-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)-4,6,12,21,27,30,33-heptaazaheptatriacontane-1,3,7,26,37-pentacarboxylic acid

Sequence: Y-(R)-DOTAGA-D-Tyr(3-I)-D-Phe-D-Lys[Sub-Glu-CO-Lys] acetate

Quality

Research Chemical

Characteristics

Molar mass 1584.27

CAS RN [not yet assigned]

Purity ≥ 95 %

  • White to off-white solid
  • soluble in water, acetonitrile

Certificates

CoA: ESI-MS (identity), HPLC (purity)

Product sheets (PDF)

Literature

Chatalic. L. S. et al. Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent. Theranostics 2016, 6, 849–861.

Add to inquiry

Product No.Filling amountQuantity
Product No.: 99390
Product was added